Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-011651

Chief Financial Officer sold 6,628 shares at an average $106.03 ($702,744)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2026-02-04 Sale 10b5-1 −1,500 $104.74 $157,115 130,665 D: show line 1 in the form
Smith Hunter C Chief Financial Officer 2026-02-04 Sale 10b5-1 −1,000 $106.60 $106,604 129,665 D: show line 2 in the form
Smith Hunter C Chief Financial Officer 2026-02-04 Sale 10b5-1 −747 $107.67 $80,426 128,918 D: show line 3 in the form
Smith Hunter C Chief Financial Officer 2026-02-05 Sale 10b5-1 −3,381 $106.06 $358,599 125,537 D: show line 4 in the form
Open-market sales · 6,628 sh · avg $106.03 · $702,744
Loading xslF345X05/tm265467-1_4seq1.xml…